OR
OSE Immunotherapeutics S.A.
ORPOF · OTC
$4.43 +0.00% (+$0.00)
Valuation
-
N/A EV/FFO N/A
P/S N/A
P/B N/A
Growth
-
N/A Rev. growth N/A
FCF growth N/A
Book val. growth N/A
Profitability
-
N/A Net margin N/A
Op. margin N/A
FCF margin N/A
Quality
-
N/A ROE N/A
ROA N/A
Asset turnover N/A
Debt
-
N/A Current ratio N/A
Int. coverage N/A
Net debt/EBITDA N/A
Stability
100 /100
Stable Beta 0.85x
EPS volatility N/A
Profitable years N/A
Bulios Scoring descrie calitatea și istoricul unei companii, nu randamentul viitor. Un scor ridicat nu este un semnal de cumpărare. Află mai multe
Întreabă StockBot despre ORPOF
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Marc Le Bozec
Employees
64
Headquarters
Nantes
Evenimente viitoare
28 SEPT.
Earnings
Upcoming earnings report